IAS 2025, the 13th IAS Conference on HIV Science, opened today with a call to accelerate access to long-acting HIV prevention and treatment innovations amid growing global funding challenges. Four ...

In the new EXPrESSIVE clinical trial program, Merck will evaluate MK-8527, a once-monthly, oral PrEP therapy, in populations at high risk of HIV-1 infection, including adolescent girls and women in ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE ...

The Microsoft co-founder is in a desperate fight against the Trump administration's foreign aid cuts, warning that the ...

Bill Gates' net worth recently saw a significant $51 billion reduction, according to the Bloomberg Billionaires Index. This ...

Misinformation fuelled by the US health secretary is creating a dangerous – and growing – lack of trust in vaccines ...

The cosmetics billionaire, the rock star, and a series of very mysterious property deals in prime Palm Beach - An ...

Thanks to a landmark deal announced on July 9 by the Global Fund, Uganda is expected to be among the first countries in sub-Saharan Africa to get access to Lenacapavir, a revolutionary new drug that ...

The laboratory, which is fully accredited by World Health Organization (WHO), was handed over today to the national authorities. Hosted at the Institut Pasteur de Madagascar in the capital, ...